FierceBiotech |
Chinese buyers mull bids for Johnson & Johnson's $4B diabetes unit: report
FierceBiotech J&J has said its evaluation of the future of the diabetes care business is ongoing. Reports that Chinese companies are among those circling the unit are in keeping with the country's increasingly global investment strategy and health trends within its ... |
from diabetes - Google News
Social Plugin